Stop MS history
Twenty-five years ago there were no disease modifying therapies (DMTs) for MS. Today there are over a dozen licensed treatments for people with relapsing forms of MS, and one for some people with primary progressive MS.
But these treatments only work for some and there are no treatments that can completely stop the progression of MS.
Decades of research have led to major advances in our understanding of MS. We’re now in a position to build on that success and Stop MS once and for all.
Our research story
We were founded in 1953 by Richard and Mary Cave, who had MS. We've been raising money for research ever since, funding our first symptom management project in 1959.
Over the years we've established the MS Tissue bank, the MS Research network and world class MS research centres in Cambridge and Edinburgh. We've funded over £218 million worth of research to find more treatments for MS and help people manage their symptoms. And we've been led every step of the way by our community of people who know MS.
We've come a long way since 1953. But we need to do more. And that means a significant investment.
“With a dramatic increase in investment over the next 10 years, there is a genuine prospect we can transform treatment for everyone with MS, including people with progressive forms. The Stop MS Appeal is pivotal to us achieving this.” Professor Alan Thompson (Consultant neurologist and Chair of Scientific Steering Committee of the International Progressive MS Alliance)
Stop MS Appeal history
We started laying the groundwork for the Stop MS Appeal in 2012 when we recruited our Stop MS steering group. They developed our vision to make MS history.
Since then we've worked closely with our steering group, Appeal Board members and Pioneers to raise money through fantastic events like our St Paul's Carol Concert and Jacqueline du Pré Tribute Concerts.
Behind the scenes, we've invested time and money building our Expert Consortium of researchers and designing incredible new trials.
An end to MS is in our grasp. Raising £100 million over ten years will revolutionise treatments and change the course of MS for everyone.